Canavan disease, a rare early-onset human spongiform leukodystrophy: Insights into its genesis and possible clinical interventions

Biochimie

Volumn 95, Issue 4, 2013, Pages 946-956

  Baslow, M H ^a   Guilfoyle, D N ^b  

^a Center for Neurochemistry   (United States)

^b Center for Advanced Brain Imaging   (United States)

Author keywords

Aspartoacylase; Brain; Canavan disease; Hypoacetylaspartia; N acetyl l aspartylglutamate; N acetylaspartate

Indexed keywords

AMIDASE; AMINO ACID; ASPARTOACYLASE; MYELIN; N ACETYL ASPARTYLGLUTAMATE; N ACETYLASPARTIC ACID; ORGANIC ANION TRANSPORTER 1; TRIACETIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN NERVE CELL; CANAVAN DISEASE; CELL METABOLISM; ENZYME ACTIVITY; EXTRACELLULAR FLUID; HUMAN; KIDNEY PROXIMAL TUBULE; MYELIN SHEATH; NERVE FIBER; OLIGODENDROGLIA; PHENOTYPE; PROTEIN EXPRESSION;

ACETATES; ANIMALS; ASPARTIC ACID; BRAIN; CANAVAN DISEASE; EXTRACELLULAR FLUID; HUMANS; MYELIN SHEATH; OSMOSIS; SIGNAL TRANSDUCTION; WATER; WATER-ELECTROLYTE BALANCE;

EID: 84874661999     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.10.023     Document Type: Article

References (82)

1. R. Matalon, and K. Michals-Matalon Molecular basis of Canavan disease Eur. J. Paediatr. Neurol. 2 1998 69 76
2. E. Bitto, C.A. Bingman, G.E. Wesenberg, J.G. McCoy, and G.N. Phillips Structure of aspartoacylase, the brain enzyme impaired in Canavan disease PNAS 104 2007 456 461
3. S.J. Perlman, and S. Mar Leukodystrophies Adv. Exptl. Med. Biol. 727 2012 154 171
4. 1H-MRS) and diffusion-weighted MRI Neuropediatrics 37 2006 209 221
5. N. Gordon Canavan disease: a review of recent developments Eur. J. Paediatr. Neurol. 5 2000 65 69
6. A. Feigenbaum, R. Moore, J. Clarke, S. Hewson, D. Chitayat, P.N. Ray, and T.L. Stockley Canavan disease: carrier-frequency determination in the ashkenazi jewish population and development of a novel molecular diagnostic assay Am. J. Med. Genet. 124A 2004 142 147
7. M.M. Canavan Schilders encephalitis periaxialis diffusa. Report of a case in a child aged sixteen and one-half months Arch. Neurol. Psychiat. 25 1931 299 308
8. M.H. Baslow, and T.R. Resnik Canavan disease: analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms J. Mol. Neurosci. 9 1997 109 126
9. O.N. Elpeleg, and A. Shaag The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-jewish patients J. Inherit. Metab. Dis. 22 1999 531 534
10. R. Matalon, and K. Michals-Matalon Recent advances in Canavan disease Adv. Pediatr. 46 1999 493 506
11. M.H. Baslow Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease. An analytical review J. Mol. Neurosci. 15 2000 61 69
12. B.J. Zeng, Z.H. Wang, L.A. Ribiero, P. Leone, R. DeGasperi, S.J. Kim, S. Raghavan, E. Ong, G.M. Pastores, and E.H. Kolodny Identification and characterization of novel mutations of aspartoacylase gene in non-Jewish patients with Canavan disease J. Inherit. Metab. Dis. 25 2002 557 570
13. M. Assadi, C. Janson, D.-J. Wang, O. Goldfarb, N. Suri, L. Bilaniuk, and P. Leone Lithium citrate reduces excessive intra-cerebral N-acetylaspartate in Canavan disease Eur. J. Paediatr. Neurol. 14 2010 354 359
14. 13C] glucose infusion J. Neurochem. 77 2001 347 350
15. M.H. Baslow Evidence supporting a role for N-acetyl-l-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review Neurochem. Int. 40 2002 295 300
16. M.H. Baslow N-acetylaspartate and N-acetylaspartylglutamate A. Lajtha, Handbook of Neurochemistry and Molecular Neurobiology third ed. Amino Acids and Peptides in the Nervous System vol 6 2007 Springer Sci. 418 (Chapter 14), 305-346
17. M.H. Baslow A novel key-lock mechanism for inactivating amino acid neurotransmitters during transit across extracellular space Amino Acids 38 2010 51 55
18. J.R. Moffett, P. Arun, P.S. Ariyannur, J.Y. Garbern, D.M. Jacobowitz, and A.M.A. Namboodiri Extensive aspartoacylase expression in the rat central nervous system Glia 59 2011 1414 1434
19. M.H. Baslow, and D.N. Guilfoyle Effect of N-acetylaspartic acid on the diffusion coefficient of water: a proton magnetic resonance phantom method for measurement of osmolyte-obligated water Analyt. Biochem. 311 2002 133 138
20. S.K. Mehta, K. Kaur, S. Sharma, and K.K. Bhasin Behavior of acetyl modified amino acids in reverse micelles: a non-invasive and physiochemical approach J. Colloid Interface Sci. 314 2007 689 698
21. M.H. Baslow, and D.N. Guilfoyle Are astrocytes the missing link between lack of brain aspartoacylase activity and the spongiform leukodystrophy in Canavan disease? Neurochem. Res. 34 2009 1523 1534
22. J. Wang, R. Matalon, B. Gita, W. Gusheng, L. Hong, L. Tong, L. Zi-Hua, and R.W. Ledeen Bimodal occurrence of aspartoacylase in myelin and cytosol of brain J. Neurochem. 101 2007 448 457
23. G. Karelson, A. Ziegler, B. Kunnecke, and J. Seelig Feeding versus infusion: a novel approach to study the NAA metabolism in rat brain NMR Biomed. 16 2003 413 423
24. D.L. Taylor, S.E.C. Davies, T.P. Obrenovitch, J. Urenjak, D.A. Richards, J.B. Clark, and L. Symon Extracellular N-acetylaspartate in rat brain: in vivo determination of basal levels and changes evoked by high K+ J. Neurochem. 62 1994 2349 2355
25. T.N. Sager, A. Fink-Jensen, and A.J. Hansen Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia J. Neurochem. 68 1997 675 682
26. A.F. D'Adamo, J.C. Smith, and C. Woiler The occurrence of N-acetylaspartate amidohydrolase (aminoacylase II) in the developing rat J. Neurochem. 20 1973 1275 1278
27. T.N. Sager, H. Laursen, and A.J. Hansen Changes in N-acetyl-aspartate content during focal and global brain ischemia of the rat J. Cereb. Blood Flow Metab. 15 1995 639 646
28. Z. Vajda, E. Berenyi, P. Bogner, I. Repa, T. Doczi, and E. Sulyok Brain adaptation to water loading in rabbits as assessed by NMR relaxometry Pediatr. Res. 46 1999 450 459
29. F.B. Goldstein Amidohydrolases of brain; enzymatic hydrolysis of N-acetyl-l-aspartate and other N-acyl-l-amino acids J. Neurochem. 26 1976 45 49
30. M.H. Baslow, R.F. Suckow, M.J. Berg, N. Marks, M. Saito, and K.K. Bhakoo Differential expression of carnosine, homocarnosine and N-acetyl-l-histidine hydrolytic activities in cultured rat macroglial cells J. Mol. Neurosci. 17 2001 351 359
31. J.J. O'Dowd, M.T. Cairns, M. Trainor, D.J. Robins, and D.J. Miller Analysis of carnosine, homocarnosine, and other histidyl derivatives in rat brain J. Neurochem. 55 1990 446 452
32. J.L. Jay, D.J. Miller, J.D. Morrison, and J.J. O'Dowd Histidyl derivatives in rabbit lens and their diminution in human cataract J. Physiol. 420 1990 155
33. J.J. O'Dowd, D.J. Robins, and D.J. Miller Detection, characterisation, and quantification of carnosine and other histidyl derivatives in cardiac and skeletal muscle Biochim. Biophys. Acta 967 1988 241 249
34. T. Fujita, H. Katsukawa, E. Yodoya, M. Wada, A. Shimada, N. Okada, A. Yamamoto, and V. Ganapathy Transport characteristics of N-acetyl-l-aspartate in rat astrocytes: involvement of sodium-coupled high-affinity carboxylate transporter NaC3/NaDC3-mediated transport system J. Neurochem. 93 2005 706 714
35. S.A. Eraly, V. Vallon, D.A. Vaughn, J.A. Gangoiti, K. Richter, M. Nagle, J.C. Monte, T. Rieg, D.M. Truong, J.M. Long, B.A. Barshop, G. Kaler, and S.K. Nigam Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice J. Biol. Chem. 281 2006 5072 5083
36. J.S. Francis, L. Strande, A. Pu, and P. Leone Endogenous aspartoacylase expression is responsive to glutamatergic activity in vitro and in vivo Glia 59 2011 1435 1446
37. M.H. Baslow, and A.P. Burlina N-acetylaspartate metabolism underlays the structural and functional units of the vertebrate brain. A bioenergetic rationale for clinical observations of changes in the neuronal biomarker "NAA" in many human brain disorders Bioenergetics Open Access 1 2012 10.4172/beg.1000102
38. M.H. Baslow Molecular water pumps and the etiology of Canavan disease; a case of the sorcerer's apprentice J. Inherit. Metab. Dis. 22 1999 99 101
39. A.-K. Meinild, D.A. Klaerke, D.D.F. Loo, E.M. Wright, and T. Zeuthen The human Na+-glucose cotransporter is a molecular water pump J. Physiol. 508 1998 15 21
40. M.H. Baslow Function of the N-acetyl-l-histidine system in the vertebrate eye. Evidence in support of a role as a molecular water pump J. Mol. Neurosci. 10 1998 193 208
41. P. Agre, L.S. King, M. Yasui, W.B. Guggino, O.P. Ottersen, Y. Fujiyoshi, A. Engel, and S. Neilsen Aquaporin water channels-from atomic structure to clinical medicine J. Physiol. 542 2002 3 16
42. B. Buffoli Aquaporin biology and nervous system Curr. Neuropharmacol. 8 2010 97 104
43. R.D. Andrew, M.W. Labron, S.E. Boehnke, L. Carnduff, and S.A. Kirov Physiological evidence that pyramidal neurons lack functional water channels Cereb. Cortex 17 2007 787 802
44. N.N. Haj-Yasein, G.F. Vindedal, M. Eilert-Olsen, G.A. Gunderson, O. Skare, P. Laake, A. Klungland, A.E. Thoren, J.M. Burkhardt, O.P. Ottersen, and E.A. Nagelhus Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet PNAS 108 2011 17815 17820
45. M.H. Baslow, J. Hrabe, and D.N. Guilfoyle Dynamic relationship between neurostimulation and N-acetylaspartate metabolism in the human visual cortex. Evidence that NAA functions as a molecular water pump during visual stimulation J. Mol. Neurosci. 32 2007 235 245
46. M.H. Baslow, C. Hu, and D.N. Guilfoyle Stimulation-induced decreases in the diffusion of extra-vascular water in the human visual cortex: a window in time and space on mechanisms of brain water transport and economy J. Mol. Neurosci. 47 2012 639 648
47. A. Darquie, J.-B. Poline, C. Poupon, H. Saint-Jalmes, and D. Le Bihan Transient decrease in water diffusion observed in human occipital cortex during visual stimulation PNAS 98 2001 9391 9395
48. D. Le Bihan, S. Urayama, A. Toshihiko, T. Hanakawa, and H. Fukuyama Direct and fast detection of neuronal activation in the human brain with diffusion MRI PNAS 103 2006 8263 8268
49. S. Pradhan, and G. Goyal Teaching NeuroImages: honeycomb appearance of the brain in a patient with Canavan disease Neurology 76 2011 e68
50. J.R. Moffett, B. Ross, P. Arun, C.N. Madhavarao, and A.M. Namboodiri N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology Prog. Neurobiol. 81 2007 89 131
51. C.N. Madhavarao, P. Arun, J.R. Moffett, S. Szucs, S. Surendran, R. Matalon, J. Garbern, D. Hristova, A. Johnson, W. Jiang, and M.A. Namboodiri Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease Proc. Natl. Acad. Sci. U. S. A. 102 2005 5221 5226
52. P.S. Ariyannur, J.R. Moffett, P. Manickam, N. Pattabiraman, P. Arun, A. Nitta, T. Nabeshima, C.N. Madhavarao, and A.M.A. Namboodiri Methamphetamine- induced neuronal protein NAT8L is the biosynthetic enzyme: Implications for specialized acetyl coenzyme A metabolism in the CNS Brain Res. 1335 2010 1 13
53. J.S. Francis, L. Strande, V. Markov, and P. Leone Aspartoacylase supports oxidative energy metabolism during myelination J. Cerebr. Blood Flow Metab. 23 May 2012 1 12 10.1038/jcbfm.2012.66
54. A.F. D'Adamo, and F.M. Yatsu Acetyl metabolism in the nervous system. N-acetyl-l-aspartic acid and the biosynthesis of brain lipids J. Neurochem. 13 1966 961 963
55. C.G. Janson, E.H. Kolodny, B.-J. Zeng, S. Raghavan, G. Pastores, P. Torres, M. Assadi, S. McPhee, O. Goldfarb, B. Saslow, A. Freese, D.J. Wang, L. Bilaniuk, D. Shera, and P. Leone Mild-onset presentation of Canvan's disease associated with novel G212A point mutation in aspartoacylase gene, 2006 Mild-onset presentation of Canvan's disease associated with novel G212A point mutation in aspartoacylase gene Ann. Neurol. 59 2006 428 431
56. M. Velinov, N. Zellers, J. Styles, and K. Wisniewski Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan disease Clin. Genet. 73 2008 288 289
57. E. Martin, A. Capone, J. Schneider, J. Hennig, and T. Thorsten Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy? Ann. Neurol. 49 2001 518 521
58. E. Wiame, D. Tyteca, N. Pierrot, F. Collard, M. Amyere, G. Noel, J. Desmedt, M.-C. Nassogne, M. Vikkula, J.-N. Octave, M.-F. Vincent, P.J. Courtoy, E. Boltshauser, and E. Van Shaftingen Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia Biochem. J. 425 2010 127 136
59. P. Arun, C.N. Madhavarao, J.R. Moffett, K. Hamilton, N.E. Grunberg, P.S. Ariyannur, W.A. Gahl, Y. Anikster, S. Mog, W.C. Hallows, J.M. Denu, and A.M. Namboodiri Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease J. Inherit. Metab. Dis. 33 2010 195 210
60. F. Gankam-Kengne, C. Nicaise, A. Soupart, A. Boom, J. Schiettecatte, R. Pochet, J.P. Brion, and G. Decaux Astrocytes are an early target in osmotic demyelination syndrome J. Am. Soc. Nephrol. 22 2011 1834 1845
61. R. Segel, Y. Anikster, S. Zevin, A. Steinberg, W.A. Gahl, D. Fisher, O. Staretz-Chacham, A. Zimran, and G. Altarescu A safety trial of high dose glyceryl triacetate for Canavan disease Mol. Genet. Metab. 2011 10.1016/j.ymgme.2011.03.012
62. D.N. Wheatley Diffusion theory, the cell and the synapse Biosystems 45 1998 151 163
63. Z. Redzic Molecular biology of the blood-brain and blood-cerebrospinal fluid barriers: similarities and differences Fluids Barriers CNS 8 2011 10.1186/2045-8118-8-3
64. E.A. Kvittingen, G. Guldal, S. Borsting, I.O. Skalpe, O. Stokke, and E. Jellum N-acetylaspartic aciduria in a child with a progressive cerebral atrophy Clin. Chim. Acta 158 1986 217 227
65. A.P. Burlina, V. Ferrari, P. Divry, W. Gradowska, C. Jakobs, M.J. Bennett, A.C. Sewell, C. Dionisi-Vici, and A.B. Burlina N- acetylaspartylglutamate in Canavan disease: an adverse effector? Eur. J. Pediatr. 158 1999 406 409
66. S. Ahmed, S. Szucs, H. Zhang, Q. Su, R. He, M. Sena-Esteves, T. Flotte, R. Matalon, and G. Gao rAAV-mediated, systemically delivered and miRNA-regulated CNS gene transfer effectively correct metabolic and psychomotor defect, alleviate neuropathology, and prolong survival of ASPA -/- mice with Canavan disease Mol. Ther. 19 2011 S249 S250 (conference abstract)
67. N. Mersmann, E.-M. Kramer-Albers, O. Teahan, and M. Klugmann Successful in vivo gene therapy for a white matter disease after adeno-associated virus vector delivery to oligodendrocytes J. Gene Med. 13 2011 7 8 424-425 (conference abstract)
68. M. Friedman, and C.E. Levin Nutritional and medicinal aspects of d-amino acids Amino Acids 42 2012 1553 1582
69. M.H. Baslow, K. Kitada, R.F. Suckow, B.L. Hungund, and T. Serikawa The effects of lithium chloride and other substances on levels of brain N-acetyl-l-aspartic acid in Canavan disease-like rats Neurochemical. Res. 27 2002 403 406
70. C.G. Janson, M. Assadi, J. Francis, L. Bilaniuk, D. Shera, and P. Leone Lithium citrate for Canavan disease Pediatr. Neurol. 33 2005 235 243
71. M.D. Edo Solsona, L.L. Fernandez, E.M. Boquet, and J.L. Andres Lithium citrate as treatment of Canavan disease Clin. Neuropharmacol. 35 2012 150 151
72. S. Zano, R. Malik, S. Szucs, R. Matalon, and R.E. Viola Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan disease Mol. Genet. Metab. 102 2011 176 180
73. M.H. Baslow, R.F. Suckow, and B.L. Hungund Effects of ethanol and of alcohol dehydrogenase inhibitors on the reduction of N-acetylaspartate levels of brain in mice in vivo. A search for substances that may have therapeutic value in the treatment of Canavan disease, an autosomally inherited recessive CNS disease J. Inherit. Metab. Dis. 23 2000 684 692
74. R. Gomez, K.L. Behar, J. Watzl, S.A. Weinzimer, B. Gulanski, G. Sanacora, J. Koretski, E. Guidone, L. Jiang, I.L. Petrakis, B. Pittman, J.H. Krystal, and G.F. Mason Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 Tesla Biol. Psychiatry 71 2011 239 246
75. P. Arun, J.R. Moffett, and A.M. Namboodiri Riluzole decreases synthesis of N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells Brain Res. 1334 2010 25 30
76. M. Wolman The spongy type of diffuse sclerosis Brain 81 1958 243 247
77. B.T. Adornato, J.S. O'Brien, P.W. Lampert, T.F. Roe, and H.B. Neustein Cerebral spongy degeneration of infancy Neurology 22 1972 202 210
78. M. Adachi, L. Schneck, J. Cara, and B.W. Volk Spongy degeneration of the central nervous system (Van Bogaert and Bertrand type; Canavan's disease) Hum. Pathol. 4 1973 331 347
79. R. Matalon, K. Michals, D. Sebesta, M. Deanching, P. Gashkoff, and J. Casanova Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease Amer. J. Med. Genet. 29 1988 463 471
80. A.O. Hession, E.G. Esrey, R.A. Croes, and C.A. Maxwell N-acetylglutamate and N-acetylaspartate in soybeans (Glycine max L.) maize (Zea maize L.), and other foodstuffs J. Agric. Food Chem. 56 2008 9121 9126
81. L. Berlinguet, and M. Laliberte Metabolism of N-acetyl-l-aspartic acid in mice Can. J. Biochem. 44 1966 783 789
82. S. Karaman, J. Barnett Jr., G.P. Sykes, B. Hong, and B. Delaney Two-generation reproductive and developmental toxicity assessment of dietary N-acetyl-l-aspartic acid in rats Food Chem. Toxicol. 49 2011 3192 3205